#Pharmaceuticals
Latest news articles tagged with "Pharmaceuticals". Follow the timeline of events, related topics, and entities.
Articles (30)
-
๐บ๐ธ Form DEF 14A ANI PHARMACEUTICALS For: 9 April
[USA]
Related: #Corporate Governance, #Regulatory Compliance
-
๐บ๐ธ ImmunityBio reports Q1 revenue of $44.2M, up 168% year-over-year
[USA]
Related: #Biotechnology, #Corporate Earnings
-
๐บ๐ธ Lillyโs weight loss pill Foundayo now available in U.S.
[USA]
Related: #Market Competition, #Healthcare Access
-
๐บ๐ธ Form DEF 14A Merck & Co. For: 8 April
[USA]
Related: #Corporate Governance, #Financial Regulation
-
๐บ๐ธ The FDA approves a new obesity pill, giving patients another option
[USA]
The daily pill called Foundayo got a fast track through the Food and Drug Administration. It will compete with the pill form of Wegovy as an alternative to obesity drugs given by injection.
Related: #Healthcare -
๐บ๐ธ Leerink reiterates Rhythm Pharmaceuticals stock rating on CHMP opinion
[USA]
Related: #Stock Market, #Regulatory Affairs
-
๐บ๐ธ Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss
[USA]
Lyme disease is an illness caused by bacteria most commonly spread to humans from ticks. It can cause arthritis, muscle weakness and pain.
Related: #Public Health -
๐บ๐ธ Insmed reports positive Phase 3b trial results for MAC lung disease drug
[USA]
Related: #Medical Trials
-
๐บ๐ธ GSK lung cancer drug receives orphan status in Japan
[USA]
Related: #Regulatory Approval
-
๐บ๐ธ Form PRE 14A TONIX
PHARMACEUTICALS HOLDING CORP. For: 20 March
[USA]
Related: #Corporate Governance
-
๐บ๐ธ IGC Pharma earnings matched, revenue fell short of estimates
[USA]
Related: #Earnings Report
-
๐บ๐ธ Tarsus Pharma general counsel Wahl sells $850k in stock
[USA]
Related: #Insider Trading
-
๐บ๐ธ Tarsus Pharma COO Neervannan Seshadri sells $772k in shares
[USA]
Related: #Insider Trading
-
๐บ๐ธ Farrow Jeffrey S of Tarsus Pharma sells $439k in shares
[USA]
Related: #Insider Trading
-
๐บ๐ธ Truist reiterates Buy on Scholar Rock stock after Roche halts rival drug
[USA]
Related: #Stock Analysis
-
๐บ๐ธ FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share
[USA]
The high-dose Wegovy helped patients with obesity lose an average 20.7% of their weight after 72 weeks in a phase three trial.
Related: #Weight Loss -
๐บ๐ธ Barclays reiterates Collegium Pharmaceutical stock rating at Overweight
[USA]
Related: #Stock Ratings
-
๐บ๐ธ Barclays reiterates Xeris Pharmaceuticals stock rating on sales outlook
[USA]
Related: #Finance
-
๐บ๐ธ Eli Lillyโs next-generation obesity drug retatrutide clears first late-stage diabetes trial
[USA]
Lilly is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and its upcoming pill, orforglipron.
Related: #Clinical Trials -
๐บ๐ธ Guardian Pharmacy prices 6M share offering at $31 per share
[USA]
Related: #Finance
-
๐บ๐ธ Ozempic Is About to Go Generic in India, China and Canada
[USA]
In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.
Related: #Market Access -
๐บ๐ธ Reviva Pharmaceuticals prices $10M public offering at $1.50
[USA]
Related: #Finance
-
๐บ๐ธ Truist initiates Altimmune stock coverage with buy rating on drug potential
[USA]
Related: #Stock Analysis
-
๐บ๐ธ Truist initiates NewAmsterdam Pharma stock coverage with buy rating
[USA]
Related: #Stock Coverage
-
๐บ๐ธ Barclays reiterates Overweight rating on ANI Pharmaceuticals stock
[USA]
Related: #Stock Ratings
-
๐บ๐ธ FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi
[USA]
Johnson & Johnson said the U.S. Food and Drug Administration approved its once-daily psoriasis pill, the first oral option to rival best-selling shots.
Related: #Healthcare -
๐บ๐ธ Blau Farmacรชutica 4Q25 slides: margin gains offset revenue miss
[USA]
Related: #Earnings Report
-
๐บ๐ธ US FDA approves J&Jโs oral psoriasis pill
[USA]
Related: #Healthcare
-
๐บ๐ธ Medicus Pharma to host fireside chat on SkinJect trial results
[USA]
Related: #Clinical Trials
-
๐ฌ๐ง India's cheap weight-loss drugs could reshape global obesity fight
[United Kingdom]
With Indiaโs semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
Related: #Healthcare
Key Entities (21)
- Food and Drug Administration (5 news)
- Truist (3 news)
- SEC filing (2 news)
- Eli Lilly (2 news)
- Barclays (2 news)
- Mycobacterium avium complex (1 news)
- Leerink Partners (1 news)
- CHMP (1 news)
- Roche (1 news)
- Semaglutide (1 news)
- Overweight (1 news)
- COO (1 news)
- Nogapendekin alfa inbakicept (1 news)
- Lyme disease (1 news)
- Pfizer (1 news)
- Tonix Pharmaceuticals (1 news)
- Orforglipron (1 news)
- Wall Street (1 news)
- Mannings (1 news)
- GSK (1 news)
- Japan (1 news)
About the topic: Pharmaceuticals
The topic "Pharmaceuticals" aggregates 30+ news articles from various countries.